![]() |
Volumn 11, Issue 3, 2002, Pages 249-264
|
Statistical determination of cost-effectiveness frontier based on net health benefits
|
Author keywords
Cost effectiveness analysis; Familywise error rate; Net health benefit; Pointwise error rate; Statistical frontier
|
Indexed keywords
NEUROLEPTIC AGENT;
ANALYTICAL ERROR;
ARTICLE;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DOUBLE BLIND PROCEDURE;
HEALTH CARE COST;
HEALTH CARE FINANCING;
HUMAN;
HYPOTHESIS;
MAJOR CLINICAL STUDY;
MEDICAL DECISION MAKING;
PRIORITY JOURNAL;
PROBABILITY;
PROSPECTIVE PAYMENT;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
STATISTICAL ANALYSIS;
ALGORITHMS;
ANTIPSYCHOTIC AGENTS;
CONFIDENCE INTERVALS;
COST-BENEFIT ANALYSIS;
DECISION MAKING;
HEALTH CARE COSTS;
HUMANS;
MODELS, STATISTICAL;
PROGRAM EVALUATION;
RANDOMIZED CONTROLLED TRIALS;
SCHIZOPHRENIA;
STOCHASTIC PROCESSES;
TREATMENT OUTCOME;
|
EID: 0036203753
PISSN: 10579230
EISSN: None
Source Type: Journal
DOI: 10.1002/hec.659 Document Type: Article |
Times cited : (10)
|
References (22)
|